Veterinary Medicines

Triclacert 5% Oral Suspension for Sheep

Authorised
  • Triclabendazole
Download as PDF

Product identification

Medicine name:
Triclaben 5% Oral Suspension for Sheep
Triclacert 5% Oral Suspension for Sheep
Active substance:
  • Triclabendazole
Target species:
  • Sheep
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Triclabendazole
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Sheep
      • Meat and offal
        56
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • Pack sizes:1L pack contains 0.8L of productContainer: High density polyethyleneClosure: Copolymer polypropylene with tamper evident sealCap Liner: Polyfaced Steran WadSpout: Polypropylene
  • Pack sizes:1L pack contains 1L of productContainer: High density polyethyleneClosure: Copolymer polypropylene with tamper evident sealCap Liner: Polyfaced Steran WadSpout: Polypropylene
  • Pack sizes:2.5L pack contains 2.2L of productContainer: High density polyethyleneClosure: Copolymer polypropylene with tamper evident sealCap Liner: Polyfaced Steran WadSpout: Polypropylene
  • Pack sizes:2.5L pack contains 2.5L of productContainer: High density polyethyleneClosure: Copolymer polypropylene with tamper evident sealCap Liner: Polyfaced Steran WadSpout: Polypropylene
  • Pack sizes:5L pack contains 5L of productContainer: High density polyethyleneClosure: Copolymer polypropylene with tamper evident sealCap Liner: Polyfaced Steran WadSpout: Polypropylene

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Medical Unlimited Company
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 08749/3076
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0142/001
Concerned member states:
  • France
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download